Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 15:12:45 2024-06-18 EDT 5-day change 1st Jan Change
76.3 USD +0.14% Intraday chart for Boston Scientific Corporation -1.02% +32.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading MT
Sector Update: Health Care MT
Top Midday Stories: Blackstone Makes $1.74 Billion Bid for Infocom; FDIC Expected to Downgrade Citigroup's 'Living Will'; Stellantis Unit to Recall Over 1 Million Vehicles MT
Silk Road Medical Shares Rally as Boston Scientific Plans Almost $1.2 Billion Acquisition MT
Correction to Boston Scientific to Buy Silk Road Article DJ
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday MT
Sector Update: Health Care MT
Boston Scientific to Acquire Silk Road Medical for $27.50 Per Share MT
Silk Road Medical Shares Surge Premarket on Boston Scientific Deal DJ
Boston Scientific to Buy Silk Road Medical for About $1.26 Billion DJ
Boston Scientific Announces Agreement to Acquire Silk Road Medical RE
Silk Road Medical to Be Acquired by Boston Scientific in $1.26 Billion Deal MT
Boston Scientific to buy Silk Road Medical for $1.16 billion RE
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc CI
Baird Adjusts Price Target on Boston Scientific to $90 From $84 MT
GE Healthcare Technologies Inc. Announces Management Changes CI
Boston Scientific Insider Sold Shares Worth $526,029, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing MT
Transcript : Boston Scientific Corporation Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 08:00 AM
Argus Adjusts Price Target on Boston Scientific to $95 From $80 MT
Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing MT
Medtronic beats quarterly profit estimates on medical devices strength RE
Citigroup Adjusts Price Target on Boston Scientific to $87 From $85, Keeps Buy Rating MT
CL King Adjusts Price Target on Boston Scientific to $90 From $82 MT
Boston Scientific Corporation Announces Positive Six-Month Results from the Ongoing Pivotal Modular ATP Clinical Trial of the mCRM System CI
Chart Boston Scientific Corporation
More charts
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
76.19 USD
Average target price
82 USD
Spread / Average Target
+7.62%
Consensus
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. News Boston Scientific Corporation
  5. CL King Adjusts Price Target on Boston Scientific to $90 From $82